Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
MSON's Cash to Debt is ranked higher than
94% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. MSON: No Debt )
MSON' s 10-Year Cash to Debt Range
Min: 0.13   Max: No Debt
Current: No Debt

Equity to Asset 0.86
MSON's Equity to Asset is ranked higher than
90% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. MSON: 0.86 )
MSON' s 10-Year Equity to Asset Range
Min: 0.5   Max: 0.89
Current: 0.86

0.5
0.89
Interest Coverage No Debt
MSON's Interest Coverage is ranked higher than
79% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. MSON: No Debt )
MSON' s 10-Year Interest Coverage Range
Min: 2.41   Max: 9999.99
Current: No Debt

2.41
9999.99
F-Score: 7
Z-Score: 18.85
M-Score: -3.31
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -8.13
MSON's Operating margin (%) is ranked higher than
61% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. MSON: -8.13 )
MSON' s 10-Year Operating margin (%) Range
Min: -35.87   Max: 23.51
Current: -8.13

-35.87
23.51
Net-margin (%) 14.36
MSON's Net-margin (%) is ranked higher than
91% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. MSON: 14.36 )
MSON' s 10-Year Net-margin (%) Range
Min: -28.56   Max: 19.78
Current: 14.36

-28.56
19.78
ROE (%) 17.74
MSON's ROE (%) is ranked higher than
92% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. MSON: 17.74 )
MSON' s 10-Year ROE (%) Range
Min: -21.42   Max: 31.93
Current: 17.74

-21.42
31.93
ROA (%) 15.01
MSON's ROA (%) is ranked higher than
96% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. MSON: 15.01 )
MSON' s 10-Year ROA (%) Range
Min: -18.21   Max: 24.04
Current: 15.01

-18.21
24.04
ROC (Joel Greenblatt) (%) -23.48
MSON's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. MSON: -23.48 )
MSON' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -91.78   Max: 50.2
Current: -23.48

-91.78
50.2
Revenue Growth (3Y)(%) 8.80
MSON's Revenue Growth (3Y)(%) is ranked higher than
83% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. MSON: 8.80 )
MSON' s 10-Year Revenue Growth (3Y)(%) Range
Min: -35.2   Max: 36.3
Current: 8.8

-35.2
36.3
» MSON's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

MSON Guru Trades in Q4 2013

Jim Simons 117,800 sh (+0.86%)
» More
Q1 2014

MSON Guru Trades in Q1 2014

Jim Simons 114,400 sh (-2.89%)
» More
Q2 2014

MSON Guru Trades in Q2 2014

Jim Simons 116,100 sh (+1.49%)
» More
Q3 2014

MSON Guru Trades in Q3 2014

Jim Simons 120,300 sh (+3.62%)
» More
» Details

Insider Trades

Latest Guru Trades with MSON

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 32.90
MSON's P/E(ttm) is ranked higher than
84% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 84.60 vs. MSON: 32.90 )
MSON' s 10-Year P/E(ttm) Range
Min: 5.18   Max: 303
Current: 32.9

5.18
303
P/B 4.70
MSON's P/B is ranked higher than
68% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. MSON: 4.70 )
MSON' s 10-Year P/B Range
Min: 0.26   Max: 5.8
Current: 4.7

0.26
5.8
P/S 4.60
MSON's P/S is ranked higher than
65% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. MSON: 4.60 )
MSON' s 10-Year P/S Range
Min: 0.12   Max: 5.68
Current: 4.6

0.12
5.68
PFCF 38.70
MSON's PFCF is ranked higher than
86% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MSON: 38.70 )
MSON' s 10-Year PFCF Range
Min: 6.92   Max: 462
Current: 38.7

6.92
462
EV-to-EBIT -49.07
MSON's EV-to-EBIT is ranked higher than
52% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. MSON: -49.07 )
MSON' s 10-Year EV-to-EBIT Range
Min: -62.4   Max: 116.6
Current: -49.07

-62.4
116.6
Current Ratio 5.74
MSON's Current Ratio is ranked higher than
88% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. MSON: 5.74 )
MSON' s 10-Year Current Ratio Range
Min: 1.55   Max: 9.22
Current: 5.74

1.55
9.22
Quick Ratio 4.09
MSON's Quick Ratio is ranked higher than
84% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. MSON: 4.09 )
MSON' s 10-Year Quick Ratio Range
Min: 0.76   Max: 7.5
Current: 4.09

0.76
7.5

Valuation & Return

vs
industry
vs
history
Price/Net Cash 16.70
MSON's Price/Net Cash is ranked higher than
89% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MSON: 16.70 )
MSON' s 10-Year Price/Net Cash Range
Min: 1.88   Max: 86.82
Current: 16.7

1.88
86.82
Price/Net Current Asset Value 8.50
MSON's Price/Net Current Asset Value is ranked higher than
89% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MSON: 8.50 )
MSON' s 10-Year Price/Net Current Asset Value Range
Min: 1.28   Max: 97.62
Current: 8.5

1.28
97.62
Price/Tangible Book 5.60
MSON's Price/Tangible Book is ranked higher than
75% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. MSON: 5.60 )
MSON' s 10-Year Price/Tangible Book Range
Min: 0.43   Max: 8.04
Current: 5.6

0.43
8.04
Price/Median PS Value 4.40
MSON's Price/Median PS Value is ranked higher than
53% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. MSON: 4.40 )
MSON' s 10-Year Price/Median PS Value Range
Min: 0.13   Max: 4.99
Current: 4.4

0.13
4.99
Price/Graham Number 2.90
MSON's Price/Graham Number is ranked higher than
83% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. MSON: 2.90 )
MSON' s 10-Year Price/Graham Number Range
Min: 0.47   Max: 8.33
Current: 2.9

0.47
8.33
Earnings Yield (Greenblatt) -2.00
MSON's Earnings Yield (Greenblatt) is ranked higher than
63% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. MSON: -2.00 )
MSON' s 10-Year Earnings Yield (Greenblatt) Range
Min: -2   Max: 6.9
Current: -2

-2
6.9

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:MX9.Germany,
Misonix Inc a New York corporation organized in 1959. The Company designs, manufactures, markets and develops minimally invasive ultrasonic medical device products. These products include the BoneScalpel cutting system which is used among other things for surgical procedures of the spine and on Maxillofacial procedures, the SonaStar Surgical Aspirator which is used to emulsify and remove soft and hard tumors, the SonicOne Wound Cleansing and Debridement System which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells and the AutoSonix ultrasound cutting and coagulating system which is distributed and marketed for Misonix through Mentor Corporation, a subsidiary of Johnson & Johnson. The Company applications include the ability to transect or shape bone, ablate and aspirate both soft and hard tissue, cleanse and debride advanced wounds and remove unwanted body fat. Among clinical specialties served are: Spine Surgery, Skull-Based Surgery (i.e., Cranio-Maxillo-Facial, Neurosurgery, Orthopedic Surgery and Plastic surgery). The Company sells its SonicOne Wound Cleansing and Debridement System, through direct sales persons and sales agents or distributors worldwide. The Companys main competitors are Johnson & Johnson, Valley Lab, a division of Tyco Healthcare, Integra Life Sciences, Inc., Sööring, and Stryker. The Companys medical device products are subject to the regulatory requirements of the U.S. Food and Drug Administration.
» More Articles for MSON

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight May 19 2013 
comment on MSON Mar 06 2013 
MISONIX Inc. (MSON) CEO Michael A Jr Mcmanus buys 5,000 Shares Dec 01 2009 
MISONIX Inc. Reports Operating Results (10-Q) Nov 16 2009 
MISONIX Inc. Reports Operating Results (10-K) Sep 28 2009 
FirstEnergy Files Application To Consolidate Transmission Assets Into PJM Aug 17 2009 
Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million Aug 05 2009 
MISONIX Inc. Reports Operating Results (10-Q) May 12 2009 
Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008 Feb 09 2009 
Misonix Announces New HIFU Distribution Agreement for Italy Jan 05 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Dec 18 2014
Novel BoneScalpel Technique Published in Operative Neurosurgery Dec 02 2014
Novel BoneScalpel Technique Published in Operative Neurosurgery Dec 02 2014
SonicOne® Study Shows Improved Wound Healing In Patients with Peripheral Vascular Disease Nov 20 2014
SonicOne® Study Shows Improved Wound Healing In Patients with Peripheral Vascular Disease Nov 20 2014
Misonix Trains Surgeons on the BoneScalpel™ at the 2014 North American Spine Society Annual... Nov 19 2014
Misonix Trains Surgeons on the BoneScalpel™ at the 2014 North American Spine Society Annual... Nov 19 2014
MISONIX INC Financials Nov 15 2014
Clinical Paper on Treatment of Burns Highlights Effectiveness of Misonix SonicOne in Burn Center... Nov 13 2014
New Data Reports Reduction in Blood Loss With Misonix SonicOne® O.R. In Burn Patients Nov 10 2014
10-Q for Misonix, Inc. Nov 08 2014
Misonix To Host BoneScalpel™ "Meet the Expert" Sessions at the 2014 North American Spine Society... Nov 07 2014
Misonix To Host BoneScalpel™ "Meet the Expert" Sessions at the 2014 North American Spine Society... Nov 07 2014
Misonix Inc Earnings Call scheduled for 4:30 pm ET today Nov 06 2014
MISONIX INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 06 2014
MISONIX INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
Misonix, Inc. Announces First Quarter Fiscal Year 2015 Financial Results Nov 06 2014
Q1 2015 Misonix Earnings Release - After Market Close Nov 06 2014
Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6,... Oct 30 2014
Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6,... Oct 30 2014
Misonix Key Opinion Leaders Train New Users at the Congress of Neurological Surgeons Annual Meeting Oct 28 2014
Misonix Key Opinion Leaders Train New Users at the Congress of Neurological Surgeons Annual Meeting Oct 28 2014
Misonix Presents "Meet the BoneScalpel™ Expert" Sessions at the Congress of Neurological Surgeons... Oct 17 2014
Misonix Presents "Meet the BoneScalpel™ Expert" Sessions at the Congress of Neurological Surgeons... Oct 17 2014
Misonix Appoints Patrick McBrayer to Board of Directors Oct 07 2014
MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of... Oct 03 2014
Misonix Supports Uganda Spine Surgery Mission with Ultrasonic BoneScalpel™ Sep 23 2014
MISONIX INC Files SEC form 10-K, Annual Report Sep 17 2014
MISONIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Sep 11 2014
Misonix Inc Earnings Call scheduled for 4:30 pm ET today Sep 10 2014
Misonix Exhibits At The 65th Southern Neurosurgical Society Annual Conference And Offers Extensive... Mar 06 2014
Misonix Reports More Than 200 Podiatry Professionals Trial the SonicOne® O.R. Mar 03 2014
Misonix, Inc. Announces Second Quarter Fiscal Year 2014 Financial Results Feb 05 2014
Misonix, Inc. To Report Second Quarter 2014 Financial Results On Wednesday, February 5, 2014 Jan 31 2014
Misonix, Inc. Enhances its Web Presence with the Unveiling of its New Website Jan 31 2014
Poster Featuring Misonix BoneScalpel™ Wins Best in Show Award at 62nd Neurological Society of... Jan 30 2014
Misonix Exhibits at the Annual New York Podiatric Clinical Conference and Offers "Hands-On"... Jan 29 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK